High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine

McNamara, LA; Topaz, N; Wang, X; Hariri, S; Fox, L; MacNeil, JR

McNamara, LA (reprint author), CDC, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2017; 66 (27): 734